2003 Competition Leads 
Pharmaceutical Technology
SEPTEMBER 22, 2022
AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008. The World Health Organization (WHO) reports that cardiovascular disease is the major leading cause of death, with 17.9 The company now faces a highly competitive generics market for its lead drug.
Cesare Ferrari
APRIL 27, 2024
In the medical device business, the capacity for innovation is commonly regarded as a key competence and a powerful response mechanism for companies operating in our complex and highly competitive environment. Poor identification of the type of innovation can lead to a poor understanding of its characteristics and full potential.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarify Health
OCTOBER 3, 2022
Niall Brennan , a leading expert on healthcare data use, privacy, and policy, moderated the discussion. Niall was also responsible for leading CMS’ first price transparency efforts, which are the foundation for the policies we have in place today. But first, let’s introduce the speakers! “Is it a good or bad thing?
Clarify Health
OCTOBER 3, 2022
Niall Brennan , a leading expert on healthcare data use, privacy, and policy, moderated the discussion. Niall was also responsible for leading CMS’ first price transparency efforts, which are the foundation for the policies we have in place today. But first, let’s introduce the speakers! “Is it a good or bad thing?
European Pharmaceutical Review
DECEMBER 21, 2022
16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure.
Healthcare Success
OCTOBER 17, 2024
Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business. Struggling with burnout while maintaining high-quality healthcare services that patients love? It was scary.
Clarivate
OCTOBER 17, 2024
Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. Pillo, Senior Healthcare Research and Data Analyst; and Paula Wade, Lead Healthcare Research and Data Analyst.
Expert insights. Personalized for you.
52 
Let's personalize your content